These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23529908)

  • 1. Assessment of control in typical childhood absence epilepsy.
    Desai J; Mitchell WG
    J Child Neurol; 2013 May; 28(5):678-9. PubMed ID: 23529908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An older drug for childhood absence epilepsy.
    Potera C
    Am J Nurs; 2010 Jun; 110(6):16. PubMed ID: 20505447
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethosuximide in childhood absence epilepsy--older and better.
    Vining EP
    N Engl J Med; 2010 Mar; 362(9):843-5. PubMed ID: 20200390
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Capparelli EV; Adamson PC;
    N Engl J Med; 2010 Mar; 362(9):790-9. PubMed ID: 20200383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
    Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Childhood and juvenile absence epilepsy. Treatment and prognosis].
    Pedersen AM; Rasmussen NH
    Ugeskr Laeger; 2004 Nov; 166(46):4133-5. PubMed ID: 15565844
    [No Abstract]   [Full Text] [Related]  

  • 8. When the past challenges the present: are older antiepileptic drugs still the best choice in childhood absence epilepsy?
    Arzimanoglou A; Ryvlin P; Perucca E
    Lancet Neurol; 2010 May; 9(5):457-9. PubMed ID: 20398853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epilepsy with myoclonic absences].
    Salas Puig J; Acebes A; González C; Tuñón A; Guisasola LM; Lahoz CH
    Neurologia; 1990; 5(7):242-5. PubMed ID: 2126943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethosuximide-induced conversion of typical childhood absence to Rolandic spikes.
    Anyanwu C; Ghavami F; Schuelein M; Motamedi GK
    J Child Neurol; 2013 Jan; 28(1):111-4. PubMed ID: 22467741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethosuximide in treatment of petit mal epilepsy].
    Kiehi Y; Ando J
    No To Shinkei; 1965 Aug; 17(8):831-40. PubMed ID: 4957471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Scientific evidence on treatment and prognosis of childhood absence epilepsy].
    Bloch J; Miranda MJ
    Ugeskr Laeger; 2017 Mar; 179(13):. PubMed ID: 28397652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastaut type-idiopathic childhood occipital epilepsy and childhood absence epilepsy: a clinically significant association?
    Verrotti A; Coppola G; D'Egidio C; Parisi P; Chiarelli F
    Seizure; 2010 Jul; 19(6):368-72. PubMed ID: 20471287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibility for provoking grand mal series in ethosuximide therapy--2 case reports].
    Findeis B
    Psychiatr Neurol Med Psychol (Leipz); 1990 Sep; 42(9):576-7. PubMed ID: 2126870
    [No Abstract]   [Full Text] [Related]  

  • 15. Childhood absence epilepsy with clinically apparent genetic and acquired burdens: a diagnostic consideration.
    Wakamoto H
    J Child Neurol; 2008 Jan; 23(1):102-5. PubMed ID: 18079316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Practical Guide to Treatment of Childhood Absence Epilepsy.
    Kessler SK; McGinnis E
    Paediatr Drugs; 2019 Feb; 21(1):15-24. PubMed ID: 30734897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile absence epilepsy exacerbated by valproic acid.
    Buechler RD; Buchhalter JR
    Pediatr Neurol; 2007 Feb; 36(2):121-4. PubMed ID: 17275666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy.
    Diluvio L; Campione E; Mordenti C; Bagnolo V; Cerminara C; Chimenti S; Bianchi L
    J Drugs Dermatol; 2013 Jan; 12(1):18-9. PubMed ID: 23377323
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of ethosuximide and valproate in the treatment of epilepsy.
    Wallace SJ
    Neurol Clin; 1986 Aug; 4(3):601-16. PubMed ID: 3092003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.